Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Update

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 4,300 shares, an increase of 207.1% from the December 31st total of 1,400 shares. Based on an average trading volume of 11,200 shares, the days-to-cover ratio is presently 0.4 days.

Invesco Nasdaq Biotechnology ETF Stock Performance

Invesco Nasdaq Biotechnology ETF stock opened at $22.65 on Friday. Invesco Nasdaq Biotechnology ETF has a fifty-two week low of $20.14 and a fifty-two week high of $24.84. The company has a market capitalization of $40.09 million, a PE ratio of 17.39 and a beta of 0.61. The company has a 50 day moving average price of $22.20 and a 200-day moving average price of $23.25.

Invesco Nasdaq Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 23rd were paid a dividend of $0.0619 per share. The ex-dividend date was Monday, December 23rd.

Institutional Trading of Invesco Nasdaq Biotechnology ETF

A number of hedge funds have recently added to or reduced their stakes in IBBQ. Strategic Financial Concepts LLC bought a new stake in Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at $1,699,000. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Invesco Nasdaq Biotechnology ETF by 22.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock worth $6,156,000 after purchasing an additional 48,137 shares during the last quarter. Finally, ORG Partners LLC bought a new stake in Invesco Nasdaq Biotechnology ETF during the third quarter valued at about $25,000.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.